Published in Interact Cardiovasc Thorac Surg on February 23, 2010
Prevention of Retained-Blood Outcomes With Active Clearance Technology | NCT02145858
Active Clearance Technology (ACT) II German Multicenter Trial | NCT02479737
Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2004) 3.38
Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol (2008) 3.17
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm (2008) 2.75
Robotic repair of posterior mitral valve prolapse versus conventional approaches: potential realized. J Thorac Cardiovasc Surg (2010) 2.69
Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J Cardiovasc Electrophysiol (2003) 2.62
An innovative, sensorless, pulsatile, continuous-flow total artificial heart: device design and initial in vitro study. J Heart Lung Transplant (2009) 2.42
Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation (2002) 2.33
Surgical treatment of postinfarction left ventricular pseudoaneurysm. Ann Thorac Surg (2007) 2.26
Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol (2007) 2.20
Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation (2003) 2.18
Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg (2010) 2.16
A randomized trial of massage therapy after heart surgery. Heart Lung (2009) 2.13
Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg (2005) 2.09
Does off-pump coronary surgery reduce morbidity and mortality? J Thorac Cardiovasc Surg (2002) 2.08
Beating heart cardioscopy: a platform for real-time, intracardiac imaging. Ann Thorac Surg (2008) 2.06
A novel device for left atrial appendage exclusion. J Thorac Cardiovasc Surg (2005) 2.04
Incidence of chest tube clogging after cardiac surgery: a single-centre prospective observational study. Eur J Cardiothorac Surg (2013) 2.03
Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol (2004) 1.92
Guidelines for reporting data and outcomes for the surgical treatment of atrial fibrillation. Ann Thorac Surg (2007) 1.91
Surgical treatment of pseudoaneurysm of the thoracic aorta. J Thorac Cardiovasc Surg (2006) 1.88
Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg (2005) 1.86
Hemolysis after mitral valve repair: mechanisms and treatment. Ann Thorac Surg (2004) 1.72
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm (2008) 1.72
Toward predictable repair of regurgitant aortic valves: a systematic morphology-directed approach to bicommissural repair. J Am Coll Cardiol (2008) 1.71
Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg (2006) 1.71
A novel running annuloplasty suture technique for robotically assisted mitral valve repair. J Thorac Cardiovasc Surg (2010) 1.68
Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol (2012) 1.66
In vivo acute performance of the Cleveland Clinic self-regulating, continuous-flow total artificial heart. J Heart Lung Transplant (2009) 1.64
Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2004) 1.63
Robotic posterior mitral leaflet repair: neochordal versus resectional techniques. Ann Thorac Surg (2012) 1.57
Percutaneous mitral valve repair for chronic ischemic mitral regurgitation: a real-time three-dimensional echocardiographic study in an ovine model. Circulation (2005) 1.57
Preoperative statin intake and morbid events after isolated coronary artery bypass grafting. J Clin Anesth (2008) 1.53
Echocardiographic insights into atrial and ventricular mechanisms of functional tricuspid regurgitation. Am Heart J (2006) 1.52
Emergency conversion in off-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg (2006) 1.50
MagScrew total artificial heart in vivo performance above 200 beats per minute. Ann Thorac Surg (2005) 1.49
Cannulation of the axillary artery with a side graft reduces morbidity. Ann Thorac Surg (2004) 1.48
"Renal dose" dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery. Crit Care Med (2005) 1.47
Mitral regurgitation associated with mitral annular dilation in patients with lone atrial fibrillation: an echocardiographic study. Echocardiography (2009) 1.46
Single-lung transplantation can be performed with acceptable outcomes using selected donors with heavy smoking history. J Heart Lung Transplant (2013) 1.46
Different determinants of residual tricuspid regurgitation after tricuspid annuloplasty: comparison of atrial septal defect and mitral valve prolapse. J Am Soc Echocardiogr (2009) 1.46
Minimally invasive versus conventional mitral valve surgery: a propensity-matched comparison. J Thorac Cardiovasc Surg (2009) 1.45
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2012) 1.45
Posterior leaflet shortening to correct systolic anterior motion after mitral valve repair. Ann Thorac Surg (2008) 1.45
Effect of epivascular cardiac autonomic nerve stimulation on cardiac function. Ann Thorac Surg (2012) 1.43
Progress on the design and development of the continuous-flow total artificial heart. Artif Organs (2012) 1.42
The impact of gender on in-hospital mortality and morbidity after isolated aortic valve replacement. Anesth Analg (2006) 1.42
Performance of extracorporeally adjustable ventricular assist device inflow cannula. Ann Thorac Surg (2010) 1.39
Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation (2005) 1.34
Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells. J Immunol (2005) 1.32
Outcomes of less invasive J-incision approach to aortic valve surgery. J Thorac Cardiovasc Surg (2012) 1.31
Mitral valve repair with Carpentier-McCarthy-Adams IMR ETlogix annuloplasty ring for ischemic mitral regurgitation: early echocardiographic results from a multi-center study. Circulation (2006) 1.24
Surgical repair of posterior mitral valve prolapse: implications for guidelines and percutaneous repair. Ann Thorac Surg (2010) 1.23
Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting? Ann Thorac Surg (2004) 1.20
Atrial glutathione content, calcium current, and contractility. J Biol Chem (2007) 1.19
Short- and long-term mortality associated with new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis. J Thorac Cardiovasc Surg (2011) 1.18
Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation (2004) 1.17
Importance of moderate ischemic mitral regurgitation. Ann Thorac Surg (2005) 1.17
Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation. Am J Cardiol (2006) 1.13
A prospective multicenter trial of bipolar radiofrequency ablation for atrial fibrillation: early results. Ann Thorac Surg (2004) 1.11
Determinants of recurrent or residual functional tricuspid regurgitation after tricuspid annuloplasty. Circulation (2006) 1.11
Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv (2003) 1.10
Speed modulation of the continuous-flow total artificial heart to simulate a physiologic arterial pressure waveform. ASAIO J (2010) 1.08
Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome. J Thorac Cardiovasc Surg (2006) 1.08
Does right thoracotomy increase the risk of mitral valve reoperation? J Thorac Cardiovasc Surg (2007) 1.07
Preclinical readiness testing of the Arrow International CorAide left ventricular assist system. Ann Thorac Surg (2004) 1.06
Annular geometry and motion in human ischemic mitral regurgitation: novel assessment with three-dimensional echocardiography and computer reconstruction. Ann Thorac Surg (2004) 1.06
Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. Ann Thorac Surg (2008) 1.06
A comprehensive review of the PARTNER trial. J Thorac Cardiovasc Surg (2013) 1.06
Heart Motion Prediction Based on Adaptive Estimation Algorithms for Robotic Assisted Beating Heart Surgery. IEEE Trans Robot (2013) 1.04
Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythm Electrophysiol (2010) 1.02
Results of matching valve and root repair to aortic valve and root pathology. J Thorac Cardiovasc Surg (2011) 1.02
Mitral valve surgery in the adult Marfan syndrome patient. Ann Thorac Surg (2006) 1.01
Axial and centrifugal continuous-flow rotary pumps: a translation from pump mechanics to clinical practice. J Heart Lung Transplant (2013) 1.01
Obstruction of St. Jude medical valves in the aortic position: plasma transforming growth factor type beta 1 in patients with pannus overgrowth. Artif Organs (2010) 1.00
Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. J Thorac Cardiovasc Surg (2008) 1.00
Modifications, classification, and outcomes of elephant-trunk procedures. Ann Thorac Surg (2013) 0.99
Ischemic mitral regurgitation: impact of the left ventricle and mitral valve in patients with left ventricular systolic dysfunction. Ann Thorac Surg (2005) 0.98
In vivo preclinical anticoagulation regimens after implantation of ventricular assist devices. Artif Organs (2009) 0.97
Phasic coronary blood flow pattern during a continuous flow left ventricular assist support. Eur J Cardiothorac Surg (2005) 0.96
Magnesium as a neuroprotectant in cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg (2006) 0.96
Bicuspid aortic valve surgery with proactive ascending aorta repair. J Thorac Cardiovasc Surg (2011) 0.95
Non-occlusive condition with the Better-Header roller pump: impacts of flow dynamics and hemolysis. Ann Thorac Cardiovasc Surg (2004) 0.95
The Cleveland Clinic PediPump: virtual fitting studies in children using three-dimensional reconstructions of cardiac computed tomography scans. ASAIO J (2008) 0.95